Pharmacokinetics of Intrvenous Alendronate-Reference-Cited by-同舟云学术

Pharmacokinetics of Intrvenous Alendronate

Published:1999-04 Issue:4 Volume:39 Page:385-393
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Cocquyt Veronique,Kline Walter F.,Gertz Barry J.,Van Belle Simon J. P.,Holland Sherry D.,DeSmet Marina,Quan Hui,Vyas Kamlesh P.,Zhang Kanying E.,De Grève Jacques,Porras Arturo G.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcemic and metastatic bone disease;Fleisch;Drug,1991

2. Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling;Chestnut;Am J Med,1995

3. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis;Liberman;N Engl J Med,1995

4. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turn over in postmenopausal women with osteoporosis;Adami;Bone,1995

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The bisphosphonates alendronate and zoledronate induce adaptations of aerobic metabolism in permanent human endothelial cells;Scientific Reports;2023-09-27

2. Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response;Frontiers in Bioengineering and Biotechnology;2022-08-17

3. Cellular and molecular actions of bisphosphonates;Bone Cancer;2022

4. Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment;Seminars in Cancer Biology;2021-01

5. Bisphosphonates: Mechanisms of Action and Role in Osteoporosis Therapy;Osteoporosis;2020